Roger Rivera, DNP

NPI: 1730697715
Total Payments
$1.1M
2024 Payments
$455,807
Companies
22
Transactions
1,786

Payment Breakdown by Category

Other$692,960 (63.6%)
Travel$300,080 (27.5%)
Consulting$64,978 (6.0%)
Food & Beverage$31,744 (2.9%)
Education$32.19 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $690,145 426 63.3%
Travel and Lodging $300,080 544 27.5%
Consulting Fee $64,978 58 6.0%
Food and Beverage $31,744 754 2.9%
Honoraria $2,815 2 0.3%
Education $32.19 2 0.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $483,927 725 $0 (2024)
Alkermes, Inc. $376,801 660 $0 (2024)
Axsome Therapeutics, Inc. $73,855 124 $0 (2024)
Vanda Pharmaceuticals Inc. $61,632 77 $0 (2024)
Teva Pharmaceuticals USA, Inc. $38,736 49 $0 (2024)
Neurocrine Biosciences, Inc. $24,387 42 $0 (2024)
Otsuka America Pharmaceutical, Inc. $11,800 32 $0 (2024)
IDORSIA PHARMACEUTICALS US INC $8,423 18 $0 (2024)
E.R. Squibb & Sons, L.L.C. $7,777 18 $0 (2024)
Janssen Scientific Affairs, LLC $1,450 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $455,807 613 ABBVIE INC. ($175,432)
2023 $370,277 632 ABBVIE INC. ($176,439)
2022 $214,880 368 Alkermes, Inc. ($113,943)
2021 $48,831 173 AbbVie Inc. ($38,678)

All Payment Transactions

1,786 individual payment records from CMS Open Payments — Page 1 of 72

Date Company Product Nature Form Amount Type
12/24/2024 ABBVIE INC. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
Category: NEUROSCIENCE
12/20/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $31.82 General
Category: Psychology/Psychiatric
12/19/2024 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Travel and Lodging In-kind items and services $814.53 General
Category: CNS
12/19/2024 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Travel and Lodging In-kind items and services $667.49 General
Category: CNS
12/19/2024 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Travel and Lodging In-kind items and services $446.19 General
Category: CNS
12/19/2024 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Food and Beverage In-kind items and services $124.77 General
Category: CNS
12/17/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $135.55 General
Category: Neuropsychiatry
12/16/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,240.00 General
Category: Psychiatry/Psychology
12/10/2024 Otsuka America Pharmaceutical, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
12/10/2024 Otsuka America Pharmaceutical, Inc. Travel and Lodging In-kind items and services $532.40 General
12/10/2024 Otsuka America Pharmaceutical, Inc. Travel and Lodging In-kind items and services $532.40 General
12/10/2024 Otsuka America Pharmaceutical, Inc. Food and Beverage In-kind items and services $146.29 General
12/07/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $36.05 General
Category: Neuropsychiatry
12/05/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,800.00 General
Category: SCHIZOPHRENIA
12/05/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,280.00 General
Category: Psychiatry/Psychology
12/05/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Travel and Lodging Cash or cash equivalent $814.16 General
Category: SCHIZOPHRENIA
12/05/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage Cash or cash equivalent $124.98 General
Category: SCHIZOPHRENIA
12/04/2024 ABBVIE INC. VRAYLAR (Drug) Travel and Lodging In-kind items and services $453.74 General
Category: NEUROSCIENCE
12/04/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $119.11 General
Category: Psychiatry/Psychology
12/04/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $16.73 General
Category: NEUROSCIENCE
12/03/2024 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Food and Beverage In-kind items and services $22.71 General
Category: CNS
12/02/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $28.57 General
Category: Psychology/Psychiatric
12/02/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $5.91 General
Category: SCHIZOPHRENIA
11/26/2024 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,800.00 General
Category: CNS
11/26/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $30.46 General
Category: NEUROSCIENCE

About Roger Rivera, DNP

Roger Rivera, DNP is a Family healthcare provider based in Kissimmee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2018. The National Provider Identifier (NPI) number assigned to this provider is 1730697715.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Roger Rivera, DNP has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $455,807 received in 2024. These payments were reported across 1,786 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($690,145).

Practice Information

  • Specialty Family
  • Other Specialties Psychiatric/Mental Health, Family
  • Location Kissimmee, FL
  • Active Since 01/12/2018
  • Last Updated 02/20/2025
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1730697715

Products in Payments

  • VRAYLAR (Drug) $483,914
  • LYBALVI (Drug) $361,313
  • Auvelity (Drug) $73,855
  • FANAPT (Drug) $61,531
  • UZEDY (Drug) $34,311
  • INGREZZA (Drug) $24,387
  • ARISTADA (Drug) $15,487
  • QUVIVIQ (Drug) $8,423
  • REXULTI (Drug) $6,922
  • COBENFY (Drug) $5,186
  • AUSTEDO (Drug) $2,970
  • CAPLYTA (Drug) $351.89
  • SPRAVATO (Drug) $135.37
  • ABILIFY MAINTENA (Drug) $110.79
  • INVEGA SUSTENNA (Drug) $105.59
  • HETLIOZ (Drug) $101.01
  • Hizentra (Biological) $90.71
  • Qelbree (Drug) $84.82
  • LATUDA (Drug) $53.84
  • JORNAY PM (Drug) $52.40

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Kissimmee